Recommendations: Edaravon, a drug with an expected neuroprotective effect, recommended as a medicine for patients with cerebral ischemic stroke (thromboembolism) (grade B). Key words: edaravon; acute ischemic stroke; xavron.
The clinical observation of treatment of a 59-year-old patient who has been diagnosed with multiple myeloma has been presented. Anemia and iron deficiency are frequent undesirable complications in patients with multiple myeloma and haematological malignancies, including those induced by chemotherapy. The article describes the modern principles ...
Abstract. The objective is to evaluate and compare the dynamics of severity of the patient’s condition and severity of neurological deficit, the state of blood rheology in persons with ischemic stroke against the background of basic therapy with the additional use of neuroprotective infusion therapy and correction of ...
1-3th of November, 2018, the IV National Congress “Stroke and Vascular Diseases” was successfully held in Kyiv. Leading specialists from Ukraine, the Czech Republic, Lithuania, Israel and the Republic of South Africa highlighted the current state of the problem of acute cerebral circulation disorder treatment and the main aspects of prevention and rehabilitation programs after...
The anesthesiologist and specialist on medical emergency conditions, Neurologist, Neurosurgeon
Abstract. Edaravone is a low-molecular-weight antioxidant drug targeting peroxyl radicals among many types of reactive oxygen species. Because of its amphiphilicity, it scavenges both lipid- and water-soluble peroxyl radicals by donating an electron to the radical. Thus, it inhibits the oxidation of lipids by scavenging chain- initiating water-soluble peroxyl radicals and chain-carrying ...
The anesthesiologist and specialist on medical emergency conditions
The aim – to explore the level of resistance to quinolines of nosocomial strains isolated from patients hospitalized in surgical hospitals in different regions of Ukraine.
General practitioner, The anesthesiologist and specialist on medical emergency conditions, Cardiologist, Neurologist, Neurosurgeon
The data of experimental studies and the experience of many years of clinical use indicate that esmolol is a unique highly effective selective ultra-short-acting beta-1-blocker for parenteral administration.
Modern medicine, having a whole arsenal of antimicrobial drugs, is not able to fully solve the problems of prevention and treatment of diseases caused by microbes.
Inflammatory infections in the urology and issues of their treatment and prevention represent one of the most pressing problems of the contemporary medicine.
The article presents data from a study on the clinical and bacteriological efficacy and safety of Brakson (tobramycin) in the treatment of complicated urinary tract infections.
The need to increase sport achievements in the setting of ever-increasing competition and approximation
of the functional capabilities of the human body to the border of reserve mechanisms make us seek
new ways to stimulate physical performance and psycho-emotional stability of athletes.
The major task faced by intensive therapy of traumatic shock is to restore the deficit in circulating blood volume (CBV) by means of infusion therapy characterized by adequate composition, volume and rate of infusion.